BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 36248991)

  • 21. Importance of local treatment in pediatric soft tissue sarcomas with microscopic residual after primary surgery: results of the Italian Cooperative Study RMS-88.
    Cecchetto G; Carli M; Sotti G; Bisogno G; Dall'Igna P; Boglino C; Granata C; Antoniello L; Guglielmi M
    Med Pediatr Oncol; 2000 Feb; 34(2):97-101. PubMed ID: 10657868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
    Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma.
    Camero S; Vitali G; Pontecorvi P; Ceccarelli S; Anastasiadou E; Cicchetti F; Flex E; Pomella S; Cassandri M; Rota R; Marampon F; Marchese C; Schiavetti A; Megiorni F
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics.
    Pal A; Chiu HY; Taneja R
    Redox Biol; 2019 Jul; 25():101124. PubMed ID: 30709791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document.
    Panda SP; Chinnaswamy G; Vora T; Prasad M; Bansal D; Kapoor G; Radhakrishnan V; Agarwala S; Laskar S; Arora B; Kaur T; Rath GK; Bakhshi S
    Indian J Pediatr; 2017 May; 84(5):393-402. PubMed ID: 28378141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
    Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
    Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA repair systems in rhabdomyosarcoma.
    Tsioli PG; Patsouris ES; Giaginis C; Theocharis SE
    Histol Histopathol; 2013 Aug; 28(8):971-84. PubMed ID: 23516236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.
    Niesen J; Brehm H; Stein C; Berges N; Pardo A; Fischer R; Ten Haaf A; Gattenlöhner S; Tur MK; Barth S
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1049-61. PubMed ID: 25433506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines.
    Marampon F; Di Nisio V; Pietrantoni I; Petragnano F; Fasciani I; Scicchitano BM; Ciccarelli C; Gravina GL; Festuccia C; Del Fattore A; Tombolini M; De Felice F; Musio D; Cecconi S; Tini P; Maddalo M; Codenotti S; Fanzani A; Polimeni A; Maggio R; Tombolini V
    Cancer Lett; 2019 Oct; 461():90-101. PubMed ID: 31325529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on molecular findings in rhabdomyosarcoma.
    El Demellawy D; McGowan-Jordan J; de Nanassy J; Chernetsova E; Nasr A
    Pathology; 2017 Apr; 49(3):238-246. PubMed ID: 28256213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: implications for patterns of disease recurrence and overall survival.
    Eaton BR; McDonald MW; Kim S; Marcus RB; Sutter AL; Chen Z; Esiashvili N
    Cancer; 2013 Apr; 119(8):1578-85. PubMed ID: 23280478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genitourinary rhabdomyosarcoma: which treatment, how much, and when?
    Wu HY; Snyder HM; Womer RB
    J Pediatr Urol; 2009 Dec; 5(6):501-6. PubMed ID: 19640790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rhabdomyosarcoma of the genitourinary sinus in children].
    Philippe-Chomette P; Orbach D; Brisse H; Aigrain Y; Berrebi D; El Ghoneimi A
    Ann Urol (Paris); 2006 Oct; 40(5):280-96. PubMed ID: 17100165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
    J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
    Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Particle beam radiation therapy for head and neck rhabdomyosarcoma in adults.
    Yang J; Gao J; Hu J; Hu W; Qiu X; Huang Q; Kong L; Lu JJ
    Ann Transl Med; 2022 Nov; 10(22):1191. PubMed ID: 36544680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rhabdomyosarcoma lysis by T cells expressing a human autoantibody based chimeric receptor targeting the fetal acetylcholine receptors].
    Gattenlöhner S
    Verh Dtsch Ges Pathol; 2006; 90():264-76. PubMed ID: 17867605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma.
    Casey DL; Wexler LH; Meyers PA; Magnan H; Chou AJ; Wolden SL
    Pediatr Blood Cancer; 2015 Mar; 62(3):445-9. PubMed ID: 25346208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype.
    Rossetti A; Petragnano F; Milazzo L; Vulcano F; Macioce G; Codenotti S; Cassandri M; Pomella S; Cicchetti F; Fasciani I; Antinozzi C; Di Luigi L; Festuccia C; De Felice F; Vergine M; Fanzani A; Rota R; Maggio R; Polimeni A; Tombolini V; Gravina GL; Marampon F
    Int J Radiat Biol; 2021; 97(7):943-957. PubMed ID: 33979259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.